CORCEPT THERAPEUTICS INC — Director's Dealing 2012

Feb 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-02-01

Reporting Person: ROE ROBERT L (President and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-01	Common stock	M	3000	$1.19	Acquired	25007	Direct
2012-02-01	Common stock	S	13000	$3.5317	Disposed	12007	Direct
2012-02-02	Common stock	M	7000	$1.19	Acquired	19007	Direct
2012-02-02	Common stock	S	7000	$3.3013	Disposed	12007	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-01	Stock option	$1.19	M	3000	Disposed	2019-03-26	Common stock (3000)	Direct
2012-02-02	Stock option	$1.19	M	7000	Disposed	2019-03-26	Common stock (7000)	Direct

Footnotes

F1: The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.

F2: Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $3.3627 to $3.60 per share. Full information on the numbers of shares sold at each sale price is available upon request.

F3: Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $3.2945 to $3.31 per share. Full information on the numbers of shares sold at each sale price is available upon request.

F4: Fully exerciseable.